- Report
- June 2024
- 200 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- January 2022
- 60 Pages
Global
From €3595EUR$3,950USD£3,082GBP
Fibrocystic Breast Condition (FBC) is a benign condition of the breast that is characterized by the presence of lumpy, fibrous tissue and cysts. It is not associated with an increased risk of breast cancer. However, it can cause discomfort and pain, and can be a source of anxiety for women. Treatment for FBC typically involves lifestyle modifications, such as avoiding caffeine and wearing a supportive bra, as well as medications, such as nonsteroidal anti-inflammatory drugs (NSAIDs) and hormonal therapies.
The FBC drug market is composed of a variety of products, including NSAIDs, hormonal therapies, and other medications. These products are used to reduce pain and discomfort associated with FBC, as well as to reduce the risk of developing breast cancer. The market is highly competitive, with a number of companies offering products for the treatment of FBC.
Some companies in the FBC drug market include Pfizer, Novartis, Merck, and AstraZeneca. Show Less Read more